BioRestorative Therapies Hosts Principal Investigator Meeting for its BRTX-100 Phase 2 Clinical Trial to Treat Chronic Lumbar Disc Disease

29.04.2022 - MELVILLE, N.Y., April 29, 2022 (GLOBE NEWSWIRE) - BioRestorative Therapies, Inc. (the “Company” or “BioRestorative”) (NASDAQ: BRTX), a clinical stage biopharmaceutical company focused on stem cell-based therapies, today announced that it is ... Seite 1

Related Keywords

United States ,Americans ,Lance Alstodt ,Chief Executive Officer ,Principal Investigator Meeting ,Principal Investigators ,